Literature DB >> 12076566

A therapeutic future for CD44 in inflammation?

Jane Bradbury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12076566     DOI： 10.1016/S0140-6736(02)08854-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.

Authors:  Xuerong Shi; Lin Leng; Tian Wang; Wenkui Wang; Xin Du; Ji Li; Courtney McDonald; Zun Chen; James W Murphy; Elias Lolis; Paul Noble; Warren Knudson; Richard Bucala
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

2.  Glycosaminoglycans are a potential cause of rheumatoid arthritis.

Authors:  Julia Y Wang; Michael H Roehrl
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.